Idexx Laboratories (IDXX) Net Income towards Common Stockholders (2009 - 2026)
Idexx Laboratories (IDXX) reported Net Income towards Common Stockholders of $338.41 million for Q2 2026, up 15.1% from $293.99 million a year earlier and up 21.5% from the prior quarter.
Powered by 
Analysis
Idexx Laboratories (IDXX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Idexx Laboratories' Net Income towards Common Stockholders came in at $1.14 billion, up 15.6% year-over-year; for FY2025, it was $1.06 billion, up 19.3% from FY2024.
- Net Income towards Common Stockholders has increased for three consecutive years, with a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- By year, Net Income towards Common Stockholders came in at $887.87 million in FY2024 (+5.1%), $845.04 million in FY2023 (+24.4%), $679.09 million in FY2022 (-8.8%) and $744.85 million in FY2021 (+28.0%).
- The Q2 2026 figure ranks as the highest quarterly Net Income towards Common Stockholders in data going back to Q2 2009.
- Year over year, Net Income towards Common Stockholders has now increased in each of the last eight quarters, with growth averaging 16.4% over the last eight quarters.
- The high point for year-over-year Net Income towards Common Stockholders in five years was Q2 2023 (growth of 69.9%); the low point was Q2 2022 (a decline of 34.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $278.45 million (Q1 2026), $248.19 million (Q4 2025) and $274.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Idexx Laboratories | 40.86 Bn | 40.07 Bn | 779.09 Mn | 338.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 338.41 Mn |
| Mar 31, 2026 | 278.45 Mn |
| Dec 31, 2025 | 248.19 Mn |
| Sep 30, 2025 | 274.61 Mn |
| Jun 30, 2025 | 293.99 Mn |
| Mar 31, 2025 | 242.68 Mn |
| Dec 31, 2024 | 216.15 Mn |
| Sep 30, 2024 | 232.84 Mn |
| Jun 30, 2024 | 203.30 Mn |
| Mar 31, 2024 | 235.58 Mn |
| Dec 31, 2023 | 194.52 Mn |
| Sep 30, 2023 | 212.23 Mn |
| Jun 30, 2023 | 224.24 Mn |
| Mar 31, 2023 | 214.05 Mn |
| Dec 31, 2022 | 172.21 Mn |
| Sep 30, 2022 | 180.94 Mn |
| Jun 30, 2022 | 131.98 Mn |
| Mar 31, 2022 | 193.97 Mn |
| Dec 31, 2021 | 162.77 Mn |
| Sep 30, 2021 | 175.24 Mn |
API Access
Idexx Laboratories Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=IDXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();